Looking for liquidity in Germany

OXFORD - Facing a moribund trading environment, some of Germany's biggest biotech names hope to offer investors more liquidity by splitting their stocks. Evotec BioSystems AG (NMarkt:EVO) and Qiagen N.V. (NMarkt:QIA; QGENF) last week announced intentions to undertake share splits

Read the full 400 word article

How to gain access

Continue reading with a
two-week free trial.